Presentation is loading. Please wait.

Presentation is loading. Please wait.

Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive.

Published byΆιμον Μιχαηλίδης Modified over 5 years ago

Similar presentations

Presentation on theme: "Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive."— Presentation transcript:

1 Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive disease  Patrick J. Geraghty, MD, Mark W. Mewissen, MD, Michael R. Jaff, DO, Gary M. Ansel, MD  Journal of Vascular Surgery  Volume 58, Issue 2, Pages e4 (August 2013) DOI: /j.jvs Copyright © 2013 Society for Vascular Surgery Terms and Conditions

2 Fig 1 Primary patency (peak systolic velocity ratio [PSVR] ≤ 2.0).
Journal of Vascular Surgery  , e4DOI: ( /j.jvs ) Copyright © 2013 Society for Vascular Surgery Terms and Conditions

3 Fig 2 Primary-assisted patency.
Journal of Vascular Surgery  , e4DOI: ( /j.jvs ) Copyright © 2013 Society for Vascular Surgery Terms and Conditions

4 Fig 3 Secondary patency. Journal of Vascular Surgery  , e4DOI: ( /j.jvs ) Copyright © 2013 Society for Vascular Surgery Terms and Conditions

5 Fig 6 Freedom from first reintervention.
Journal of Vascular Surgery  , e4DOI: ( /j.jvs ) Copyright © 2013 Society for Vascular Surgery Terms and Conditions

6 Fig 4 (online only) Primary patency using alternate criterion of peak systolic velocity ratio (PSVR) ≤ 2.5. Journal of Vascular Surgery  , e4DOI: ( /j.jvs ) Copyright © 2013 Society for Vascular Surgery Terms and Conditions

7 Fig 5 (online only) Primary patency using alternate criterion of peak systolic velocity ratio (PSVR) ≤ 3.0. Journal of Vascular Surgery  , e4DOI: ( /j.jvs ) Copyright © 2013 Society for Vascular Surgery Terms and Conditions

Download ppt "Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive."

Similar presentations

Superficial Femoral Artery Recanalization with Self-expanding Nitinol Stents: Long-term Follow-up Results  M. Ferreira, L. Lanziotti, M. Monteiro, G.

Superficial Femoral Artery Recanalization with Self-expanding Nitinol Stents: Long-term Follow-up Results  M. Ferreira, L. Lanziotti, M. Monteiro, G.
Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease  Yiu Che Chan, MBBS, MD, FRCS, Stephen.

Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease  Yiu Che Chan, MBBS, MD, FRCS, Stephen.
A review of 100 consecutive reconstructions of the distal vertebral artery for embolic and hemodynamic disease  Ramon Berguer, MD, PhD, Mark D. Morasch,

A review of 100 consecutive reconstructions of the distal vertebral artery for embolic and hemodynamic disease  Ramon Berguer, MD, PhD, Mark D. Morasch,
Improved graft patency and altered remodeling in infrainguinal vein graft reconstruction for aneurysmal versus occlusive disease  Gilbert R. Upchurch,

Improved graft patency and altered remodeling in infrainguinal vein graft reconstruction for aneurysmal versus occlusive disease  Gilbert R. Upchurch,
Mid-term outcomes of endovascular popliteal artery aneurysm repair

Mid-term outcomes of endovascular popliteal artery aneurysm repair
Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease  Yiu Che Chan, MBBS, MD, FRCS, Stephen.

Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease  Yiu Che Chan, MBBS, MD, FRCS, Stephen.
Duplex criteria for determination of in-stent stenosis after angioplasty and stenting of the superficial femoral artery  Donald T. Baril, MD, Robert Y.

Duplex criteria for determination of in-stent stenosis after angioplasty and stenting of the superficial femoral artery  Donald T. Baril, MD, Robert Y.
Comparison of surgical bypass with angioplasty and stenting of superficial femoral artery disease  Mahmoud B. Malas, MD, MHS, Ngozi Enwerem, MBBS, Umair.

Comparison of surgical bypass with angioplasty and stenting of superficial femoral artery disease  Mahmoud B. Malas, MD, MHS, Ngozi Enwerem, MBBS, Umair.
Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease  Yiu Che Chan, MBBS, MD, FRCS, Stephen.

Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease  Yiu Che Chan, MBBS, MD, FRCS, Stephen.
Primary stenting of femoropopliteal atherosclerotic lesions using new helical interwoven nitinol stents  Yiu Che Chan, MBBS, BSc, MD, FRCS, Stephen W.

Primary stenting of femoropopliteal atherosclerotic lesions using new helical interwoven nitinol stents  Yiu Che Chan, MBBS, BSc, MD, FRCS, Stephen W.
Results of polytetrafluoroethylene-covered nitinol stents crossing the inguinal ligament  Keith D. Calligaro, MD, Praveen Balraj, MD, Neil Moudgill, MD,

Results of polytetrafluoroethylene-covered nitinol stents crossing the inguinal ligament  Keith D. Calligaro, MD, Praveen Balraj, MD, Neil Moudgill, MD,
Comparison of covered stents versus bare metal stents for treatment of chronic atherosclerotic mesenteric arterial disease  Gustavo S. Oderich, MD, Luke.

Comparison of covered stents versus bare metal stents for treatment of chronic atherosclerotic mesenteric arterial disease  Gustavo S. Oderich, MD, Luke.
Karan Garg, MD, Caron B. Rockman, MD, Billy J. Kim, MD, Glenn R

Karan Garg, MD, Caron B. Rockman, MD, Billy J. Kim, MD, Glenn R
Stenting of femoropopliteal lesions using interwoven nitinol stents

Stenting of femoropopliteal lesions using interwoven nitinol stents
First clinical trial of nitinol self-expanding everolimus-eluting stent implantation for peripheral arterial occlusive disease  Johannes Lammer, MD, Marc.

First clinical trial of nitinol self-expanding everolimus-eluting stent implantation for peripheral arterial occlusive disease  Johannes Lammer, MD, Marc.
Role of simple and complex hybrid revascularization procedures for symptomatic lower extremity occlusive disease  Hasan H. Dosluoglu, MD, Purandath Lall,

Role of simple and complex hybrid revascularization procedures for symptomatic lower extremity occlusive disease  Hasan H. Dosluoglu, MD, Purandath Lall,
Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease 

Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease 
Drug-Coated Balloon Angioplasty Confers No Advantage in the Treatment of Femoropopliteal Disease When Stenting Is Required  Brian Tiu, MD, Michael Shih,

Drug-Coated Balloon Angioplasty Confers No Advantage in the Treatment of Femoropopliteal Disease When Stenting Is Required  Brian Tiu, MD, Michael Shih,
Ali F. AbuRahma, MD, J. David Hayes, MD, Sarah K

Ali F. AbuRahma, MD, J. David Hayes, MD, Sarah K
Impact of diabetes mellitus on outcomes of superficial femoral artery endoluminal interventions  Andrew M. Bakken, MD, Eugene Palchik, MD, Joseph P. Hart,

Impact of diabetes mellitus on outcomes of superficial femoral artery endoluminal interventions  Andrew M. Bakken, MD, Eugene Palchik, MD, Joseph P. Hart,

Similar presentations

Ads by Google